The global multi-therapy infusion pumps market size is projected to reach US$ 370.4 million in 2023. Over the next ten years, global multi-therapy infusion pump sales are likely to soar at 6.6% CAGR. By 2033, total market valuation is anticipated to surpass US$ 699.4 million.
Multi-therapy infusion pumps are innovative drug delivery devices used for various therapeutic purposes. They are mostly employed for administration of medications and fluids into a patient’s body in a controlled manner.
Multi-therapy infusion pumps can safely and effectively deliver fluids in small or large amounts. They are being used in hospitals, clinics, and home care settings to accurately deliver nutrients and medications such as antibiotics, hormones, chemotherapy drugs, etc.
The ability of multi-therapy infusion pumps to accurately deliver multiple infusion therapies is making them quite popular. These pumps can deliver optimized patient outcomes and reduce the chances of errors.
Multi-therapy infusion pumps are becoming ideal alternatives to manual fluid administration pumps. This is because they can deliver fluids at precise frequencies, intervals, and volumes. Growing awareness about the benefits of these pumps will play a key role in fueling their demand.
Multi-therapy infusion pumps help users to meet the demanding clinical needs of today’s patients by allowing accurate delivery of medication and fluids and medication in a controlled manner.
Increasing prevalence of chronic diseases is providing a strong impetus to the growth of the multi-therapy infusion pumps industry.
Multi-therapy infusion pumps are being increasingly used to provide medication and nutrition to patients suffering from chronic illnesses such as cancer, malnutrition, gastrointestinal disorders, etc. Hence, rise in cases of diseases will eventually bolster multi-therapy infusion pump sales.
Growing awareness regarding health procedures and surgery aftercare , and rising popularity of homecare medical devices is likely to further boost the market.
Rising adoption of multi-therapy infusion pumps in home care settings is throwing a new light into the global multi-therapy infusion pumps industry.
Today, people are spending large amounts on purchasing portable medical devices such as multi-therapy infusion pumps to reduce hospital expenses. This is expected to create a slew of opportunities for the multi-therapy infusion manufacturers during the forecast period.
The deployment of multi-therapy infusion pumps at home to decrease hospital spending is propelling market expansion. Further, the impact of technological improvements in healthcare and therapeutic services is being expanded and made more accessible.
Infusion pump technological advancements result in the prevention of drug errors and increase patient care and satisfaction. These advances lead to better clinical outcomes by using patient monitoring technology to inform and guide clinicians' treatment decisions.
The increased prevalence of diabetes worldwide, rising healthcare costs, and the introduction of innovative technologies for the creation of devices such as insulin patch pumps will positively impact the market.
Leading players are focusing on launching new and advanced solutions for varied clinical uses in hospital, homecare, and ambulatory settings. By combining high-end volumetric infusion pump functionality with compact size and low weight, companies are developing novel solutions that offer ease of use and reliability.
For instance, in April 2023, Avoset, a novel connected infusion multi-therapy ambulatory infusion system, was introduced by Eitan Medical. The new drug delivery solution is designed to enhance patient safety and improve user experience. Featuring a simplified & compact technology, Avoset can continuously monitor infusion treatment data remotely.
Development of these drug delivery solutions will help companies to increase their sales, expand their customer base, and solidify their position in the global market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Challenges for Companies/Manufacturers in the Multi-therapy Infusion Pumps Industry:
Opportunities in the Multi-therapy Infusion Pumps Industry:
Latest Trends in the Multi-therapy Infusion Pumps Market:
| Attribute | Key Insights |
|---|---|
| Estimated Global Multi-Therapy Infusion Pumps Market Size (2023) | US$ 370.4 million |
| Projected Multi-Therapy Infusion Pumps Market Projected Value (2033) | US$ 699.4 million |
| Value-based CAGR (2023 to 2033) | 6.6% |
From 2018 to 2022, the global multi-therapy infusion pumps industry experienced a CAGR of 7.3%. Total market value at the end of 2022 reached around US$ 347.9 million.
Looking ahead, the global multi-therapy infusion pumps industry is anticipated to rise at a CAGR of 6.6% from 2023 to 2033. During the forecast period, the market value is expected to reach US$ 699.4 million.
Growth in the market is driven by rising prevalence of chronic disease along with the increasing geriatric population.
Infusion pump technology was brought into healthcare 45 years ago. Its main purpose was to monitor the rate and volume of intravenous drugs to improve safety when providing cardiovascular medication. The smart pump's principal role is to provide the correct dose.
The multi-therapy infusion pumps industry is expected to continue its growth trajectory from 2023 to 2033. Rising demand for ambulatory infusion pumps and growing volume of surgical procedures will boost the market.
Most multi-therapy infusion pumps have built-in safety mechanisms and alarms for operator alerts that will trigger in the event of a malfunction. Several illnesses, including immunological deficiencies, cancer, and congestive heart failure, cannot be managed with oral drugs. They must be treated with infusion therapy.
The need for infusion pumps is predicted to increase significantly as the prevalence of diseases such as diabetes, cancer, and heart disease is expected to rise due to rapid lifestyle changes. This in turn will create lucrative opportunities for multi-therapy infusion manufacturing companies.
Principal Consultant
Rising Prevalence of Chronic Diseases Driving Multi-therapy Infusion Pump Demand in the United States
| Country | United States |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 198.0 million |
| CAGR % from 2023 to End of Forecast (2033) | 6.1% |
The United States multi-therapy infusion pumps market is expected to reach a valuation of US$ 198.0 million by 2033, expanding at a CAGR of 6.1%. Demand for multi-therapy infusion pumps in the United States is expected to rise due to the growing prevalence of chronic diseases.
Six out of every ten Americans have a chronic health condition, such as stroke or cardiovascular disease, tumors, or diabetic mellitus. To effectively and continuously deliver medicine and fluids to disease, multi-therapy infusion pumps are used.
Availability of advanced products and strong presence of leading multi-therapy infusion companies are also influencing the United States market expansion.
High Adoption of Infusion Pumps in Analgesic Therapy Boosting the United Kingdom Market
| Country | United Kingdom |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 45.2 million |
| CAGR % from 2023 to End of Forecast (2033) | 7.9% |
The multi-therapy infusion pumps industry in the United Kingdom is projected to top a valuation of US$ 45.2 million by 2033. Overall sales of multiple-therapy infusion pumps in the country are likely to soar at 7.9% CAGR during the forecast period.
The United Kingdom market is projected to experience growth owing to the rising demand for analgesic infusion pumps in pain management.
As analgesic infusion pumps can provide focused pain management while minimizing side effects, their use in surgical procedures is growing. This in turn is providing impetus for the growth of the market for multi-therapy infusion pumps.
Government Focus on Product Development to Boost China Multi-therapy Infusion Pumps Industry
| Country | China |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 16.2 million |
| CAGR % from 2023 to the End of Forecast (2033) | 6.3% |
According to Future Market Insights (FMI), China multi-therapy infusion pumps industry is anticipated to reach a valuation of US$ 16.2 million by 2033. Total demand for multi-therapy infusion pumps in the country is forecast to surge at 6.3% CAGR during the forecast period.
Growth in the market is expected to be driven by government’s favorable regulations for product developments. The Chinese government has created medical equipment regulatory frameworks and standards, including infusion pumps.
In China, the National Medical Products Administration (NMPA) is the regulatory body in charge of guaranteeing the safety and efficacy of medical devices. They enforce legislation, develop standards, and perform inspections to verify that quality and safety criteria are met.
China’s exploding population and surge in cases of various chronic diseases will also positively influence multi-therapy infusion pump demand during the next ten years.
Increasing Adoption of Home Healthcare Services to Drive Japan Multi-therapy Infusion Pumps Market
| Country | Japan |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 14.2 million |
| CAGR % from 2023 to the End of Forecast (2033) | 7.1% |
Japan multi-therapy infusion pumps industry is projected to cross a valuation of US$ 14.2 million by 2033. It is likely to exhibit a CAGR of 7.1% from 2023 to 2033.
Rising adoption of home healthcare services is emerging as a key factor driving multi-therapy infusion pump demand in Japan.
Home healthcare services have been growing in Japan to support elderly and chronically ill patients. Infusion pumps play a vital role in enabling the administration of intravenous medications or fluids in a home setting, which increases the demand for these devices.
Improved Healthcare Infrastructure Making Korea a Lucrative Market for Manufacturers
| Country | South Korea |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 8.0 million |
| CAGR % from 2023 to the End of Forecast (2033) | 6.8% |
As per Future Market Insights, multi-therapy infusion pump demand in Korea is expected to rise at 6.8% CAGR during the assessment period. Total market valuation in Korea is anticipated to reach a valuation of US$ 8.0 million.
South Korea has a well-developed healthcare system with advanced medical facilities. Hospitals and healthcare institutions require a significant number of infusion pumps to support patient care and treatment.
Further, infusion pump technology continues to evolve, offering improved features such as better accuracy, safety mechanisms, and programmable settings which is aiding the market growth in the country.
Demand to Remain High for Table Top Multi-Therapy Infusion Pumps
According to Future Market Insights (FMI), table top segment is expected to dominate the multi-therapy infusion pumps industry. This is due to rising popularity of table top multi-therapy infusion pumps on account of their various attractive features.
Tabletop multi-therapy infusion pumps are medical equipment that may administer various therapies at the same time or sequentially. They include innovative features that ensure correct and controlled administration of fluids and drugs.
The table top segment is anticipated to progress at a CAGR of 6.2% from 2023 to 2033. It will hold a prominent share of the global market by the end of 2033.
Demand for tabletop multi-therapy infusion pumps is likely to remain high in the market due to their smooth and continuous mode of operation and unparalleled ease of use. Hence, companies must expand their table top infusion pumps portfolios to maximize their profits.
Parenteral Nutrition to Create Lucrative Growth Prospects for the Market
Parenteral nutrition segment is expected to lead the multi-therapy infusion pumps industry. It is likely to thrive at a CAGR of 7.4% from 2023 to 2033, making it one of the lucrative application segments.
The target segment will capture a significant market share in 2023. This is due to the increasing need for personalized nutritional therapy and ability of infusion pumps to quickly deliver specialized food forms.
Rising need for individualized nutrition therapy is assisting in the expansion of the parenteral nutrition market sector. This in turn is creating high demand for multi-therapy pumps.
Multi-therapy infusion pumps provide precise control over infusion rates and volumes. This is critical in personalizing PN therapy to each patient's individual nutritional needs. Depending on the patient's needs, the pump can be configured to supply different components of the PN solution at varying rates.
Rising incidence of malnutrition especially among hospitalized patients will further boost growth of the target segment.
As per a report published in the National Library of Medicine (NLM), malnutrition has become a highly prevalent condition in the acute hospital setting. It affects around 40% of hospitalized patients. To prevent or treat malnutrition, healthcare workers use multi-therapy infusion pumps.
Hospitals to Remain Leading End-users of Multi-Therapy Infusion Pumps
As per the latest analysis, hospitals will remain the leading end user of multi-therapy infusion pumps. This is due to the high demand for critical patient care in the hospitals.
The hospitals segment is anticipated to progress at 7.2% CAGR between 2023 and 2033. It will hold a dominant share of the global multi-therapy infusion pumps industry by the end of 2033.
In pediatric hospitals, multi-therapy infusion pumps are commonly used to provide drugs and fluids to children. Their configurable features and safety mechanisms are notably useful for ensuring proper dosing and reducing pharmaceutical mishaps.
Similarly, in intensive care units (ICUs) and other critical care settings, multi-therapy infusion pumps are very important. They aid in the administration of numerous drugs, including vasopressors, sedatives, and antiarrhythmics, to stabilize patients and manage critical circumstances. Due to mentioned factors, the adoption of multi-therapy infusion pumps in hospitals is high.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The multi-therapy infusion pumps industry is highly competitive, with numerous players vying for market share. In such a scenario, key multi-therapy infusion pump manufacturers must adopt effective strategies to stay ahead of the competition.
Key Strategies Adopted by the Players:
Companies invest heavily in research and development to deliver novel products that improve efficiency, dependability, and cost-effectiveness. Product innovation allows businesses to differentiate themselves from their competition while also catering to the changing demands of their clients.
Key industry leaders frequently develop strategic partnerships and collaborations with other companies in order to harness their strengths and increase their market reach. Companies might also gain access to new technology and markets through such agreements.
Key players in the multi-therapy infusion pump industry often engage in mergers and acquisitions to strengthen their position, expand their product portfolio, and gain access to new markets.
Key Developments in the Multi-Therapy Infusion Pumps Industry:
| Attribute | Details |
|---|---|
| Market Size Value in 2023 | US$ 370.4 million |
| Market Forecast Value in 2033 | US$ 699.4 million |
| Anticipated Growth Rate (2023 to 2033) | 6.6% CAGR |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | Volume (MT) and Value (US$ Million) |
| Key Regions Covered | Latin America; North America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | Canada, United States, Mexico, Brazil, Chile, Peru, Argentina, Germany, France, Italy, Spain, United Kingdom, Netherlands, Belgium, Nordic, Russia, Poland, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Singapore, Australia, New Zealand, GCC Countries, South Africa, Central Africa, and others |
| Key Market Segments Covered | Product Type, Nature, Form, Processing Type, Packaging Format, Sales Channel, and Region |
| Key Companies Profiled | MOOG Inc.; pfm medical ag; BD; AVA Biomedical; ICU medical; ANGEL Electronics; B. Braun |
The demand for portable and user-friendly infusion pump systems is driving the market.
Product approval procedures, safety requirements, and market entrance obstacles.
Smart infusion systems and wireless connectivity for remote monitoring.
Technical improvements in the demand for precise drug delivery is surging the market expansion.
North America is dominating the multi-therapy infusion pumps market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value-Added Insights
4.1. Product Adoption / Usage Analysis
4.2. Product Features/ USP’s
4.3. Technological Assessment
4.4. Regulatory Landscape
4.5. Recent Product Approvals/Launches
4.6. PESTEL Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Life Expectancy Outlook
5.1.4. Global Ambulatory Infusion Pumps Market (Parent Market Analysis)
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Growing Geriatric Population Rate
5.2.3. Favourable Government Regulations
5.2.4. Rising Demand for Homecare Services
5.2.5. Technological Advancement
5.2.6. Increasing Prevalence of Chronic Diseases
5.2.7. Increasing Product Approvals and Launches
5.3. Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis – Impact Assessment
6.1. COVID-19 and Impact Analysis
6.1.1. By Modality
6.1.2. By Application
6.1.3. By End User
6.1.4. By Region
6.2. 2023 Market Scenario
7. Global Market Volume (in Units) Analysis 2018 to 2022 and Forecast, 2023 to 2033
7.1. Historical Volume (in Units) Analysis, 2018 to 2022
7.2. Current and Future Volume (in Units) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis By Modality
8.2. Pricing Break-up
8.2.1. Manufacturer-Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ million) Analysis 2018 to 2022 and Forecast, 2023 to 2033
9.1. Historical Market Value (US$ Million) Analysis, 2018 to 2022
9.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Modality
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Modality, 2018 to 2022
10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Modality, 2023 to 2033
10.3.1. Pole Mounted
10.3.2. Table Top
10.4. Market Attractiveness Analysis By Modality
11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By Application, 2018 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033
11.3.1. Parenteral Nutrition
11.3.2. Analgesic Therapy
11.3.3. Chemotherapy
11.3.4. Antibiotic Therapy
11.3.5. Desferal Therapy
11.3.6. Chronotherapy
11.4. Market Attractiveness Analysis By Application
12. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis By End User, 2018 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
12.3.1. Hospitals
12.3.2. Specialty Clinics
12.3.3. Ambulatory clinics
12.3.4. Homecare Setting
12.4. Market Attractiveness Analysis By End User
13. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2018 to 2022
13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East and Africa
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2018 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. United States
14.3.1.2. Canada
14.3.2. By Modality
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Modality
14.4.3. By Application
14.4.4. By End User
14.5. Country-Level Analysis & Forecast
14.5.1. United States Market Analysis
14.5.1.1. .Introduction
14.5.1.2. Market Analysis and Forecast by Market Taxonomy
14.5.1.2.1. By Modality
14.5.1.2.2. By Application
14.5.1.2.3. By End User
14.5.2. Canada Market Analysis
14.5.2.1. Introduction
14.5.2.2. Market Analysis and Forecast by Market Taxonomy
14.5.2.2.1. By Modality
14.5.2.2.2. By Application
14.5.2.2.3. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2018 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Modality
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Modality
15.4.3. By Application
15.4.4. By End User
15.5. Country-Level Analysis & Forecast
15.5.1. Brazil Market Analysis
15.5.1.1. .Introduction
15.5.1.2. Market Analysis and Forecast by Market Taxonomy
15.5.1.2.1. By Modality
15.5.1.2.2. By Application
15.5.1.2.3. By End User
15.5.2. Mexico Market Analysis
15.5.2.1. Introduction
15.5.2.2. Market Analysis and Forecast by Market Taxonomy
15.5.2.2.1. By Modality
15.5.2.2.2. By Application
15.5.2.2.3. By End User
15.5.3. Argentina Market Analysis
15.5.3.1. Introduction
15.5.3.2. Market Analysis and Forecast by Market Taxonomy
15.5.3.2.1. By Modality
15.5.3.2.2. By Application
15.5.3.2.3. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2018 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. France
16.3.1.3. Italy
16.3.1.4. United Kingdom
16.3.1.5. Spain
16.3.1.6. Russia
16.3.1.7. BENELUX
16.3.1.8. Rest of Europe
16.3.2. By Modality
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Modality
16.4.3. By Application
16.4.4. By End User
16.5. Country-Level Analysis & Forecast
16.5.1. Germany Market Analysis
16.5.1.1. .Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Modality
16.5.1.2.2. By Application
16.5.1.2.3. By End User
16.5.2. France Market Analysis
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Modality
16.5.2.2.2. By Application
16.5.2.2.3. By End User
16.5.3. Italy Market Analysis
16.5.3.1. Introduction
16.5.3.2. Market Analysis and Forecast by Market Taxonomy
16.5.3.2.1. By Modality
16.5.3.2.2. By Application
16.5.3.2.3. By End User
16.5.4. United Kingdom Market Analysis
16.5.4.1. .Introduction
16.5.4.2. Market Analysis and Forecast by Market Taxonomy
16.5.4.2.1. By Modality
16.5.4.2.2. By Application
16.5.4.2.3. By End User
16.5.5. Spain Market Analysis
16.5.5.1. .Introduction
16.5.5.2. Market Analysis and Forecast by Market Taxonomy
16.5.5.2.1. By Modality
16.5.5.2.2. By Application
16.5.5.2.3. By End User
16.5.6. Russia Market Analysis
16.5.6.1. .Introduction
16.5.6.2. Market Analysis and Forecast by Market Taxonomy
16.5.6.2.1. By Modality
16.5.6.2.2. By Application
16.5.6.2.3. By End User
16.5.7. BENELUX Market Analysis
16.5.7.1. .Introduction
16.5.7.2. Market Analysis and Forecast by Market Taxonomy
16.5.7.2.1. By Modality
16.5.7.2.2. By Application
16.5.7.2.3. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2018 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Modality
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Modality
17.4.3. By Application
17.4.4. By End User
17.5. Country-Level Analysis & Forecast
17.5.1. India Market Analysis
17.5.1.1. .Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Modality
17.5.1.2.2. By Application
17.5.1.2.3. By End User
17.5.2. Thailand Market Analysis
17.5.2.1. .Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Modality
17.5.2.2.2. By Application
17.5.2.2.3. By End User
17.5.3. Indonesia Market Analysis
17.5.3.1. Introduction
17.5.3.2. Market Analysis and Forecast by Market Taxonomy
17.5.3.2.1. By Modality
17.5.3.2.2. By Application
17.5.3.2.3. By End User
17.5.4. Malaysia Market Analysis
17.5.4.1. Introduction
17.5.4.2. Market Analysis and Forecast by Market Taxonomy
17.5.4.2.1. By Modality
17.5.4.2.2. By Application
17.5.4.2.3. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2018 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Modality
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Modality
18.4.3. By Application
18.4.4. By End User
18.5. Country-Level Analysis & Forecast
18.5.1. China Market Analysis
18.5.1.1. .Introduction
18.5.1.2. Market Analysis and Forecast by Market Taxonomy
18.5.1.2.1. By Modality
18.5.1.2.2. By Application
18.5.1.2.3. By End User
18.5.2. Japan Market Analysis
18.5.2.1. Introduction
18.5.2.2. Market Analysis and Forecast by Market Taxonomy
18.5.2.2.1. By Modality
18.5.2.2.2. By Application
18.5.2.2.3. By End User
18.5.3. South Korea Market Analysis
18.5.3.1. Introduction
18.5.3.2. Market Analysis and Forecast by Market Taxonomy
18.5.3.2.1. By Modality
18.5.3.2.2. By Application
18.5.3.2.3. By End User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2018 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Modality
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Modality
19.4.3. By Application
19.4.4. By End User
19.5. Country-Level Analysis & Forecast
19.5.1. Australia Market Analysis
19.5.1.1. .Introduction
19.5.1.2. Market Analysis and Forecast by Market Taxonomy
19.5.1.2.1. By Modality
19.5.1.2.2. By Application
19.5.1.2.3. By End User
19.5.2. New Zealand Market Analysis
19.5.2.1. Introduction
19.5.2.2. Market Analysis and Forecast by Market Taxonomy
19.5.2.2.1. By Modality
19.5.2.2.2. By Application
19.5.2.2.3. By End User
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
20. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2018 to 2022
20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Türkiye
20.3.1.3. Northern Africa
20.3.1.4. South Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Modality
20.3.3. By Application
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Modality
20.4.3. By Application
20.4.4. By End User
20.5. Country-Level Analysis & Forecast
20.5.1. GCC Countries Market Analysis
20.5.1.1. .Introduction
20.5.1.2. Market Analysis and Forecast by Market Taxonomy
20.5.1.2.1. By Modality
20.5.1.2.2. By Application
20.5.1.2.3. By End User
20.5.2. Türkiye Market Analysis
20.5.2.1. Introduction
20.5.2.2. Market Analysis and Forecast by Market Taxonomy
20.5.2.2.1. By Modality
20.5.2.2.2. By Application
20.5.2.2.3. By End User
20.5.3. Northern Africa Market Analysis
20.5.3.1. Introduction
20.5.3.2. Market Analysis and Forecast by Market Taxonomy
20.5.3.2.1. By Modality
20.5.3.2.2. By Application
20.5.3.2.3. By End User
20.5.4. South Africa Market Analysis
20.5.4.1. Introduction
20.5.4.2. Market Analysis and Forecast by Market Taxonomy
20.5.4.2.1. By Modality
20.5.4.2.2. By Application
20.5.4.2.3. By End User
20.6. Market Trends
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Branding and Promotional Strategies, By Key Players
22.3. Key Development Analysis
22.4. Competition Deep Dive
22.4.1. MOOG Inc.
22.4.1.1. Overview
22.4.1.2. Product Portfolio
22.4.1.3. Key Financials
22.4.1.4. Sales Footprint
22.4.1.5. SWOT Analysis
22.4.1.6. Strategy Overview
22.4.1.6.1. Marketing Strategy
22.4.1.6.2. Product Strategy
22.4.1.6.3. Channel Strategy
22.4.2. PFM medical ag
22.4.2.1. Overview
22.4.2.2. Product Portfolio
22.4.2.3. Key Financials
22.4.2.4. Sales Footprint
22.4.2.5. SWOT Analysis
22.4.2.6. Strategy Overview
22.4.2.6.1. Marketing Strategy
22.4.2.6.2. Product Strategy
22.4.2.6.3. Channel Strategy
22.4.3. BD
22.4.3.1. Overview
22.4.3.2. Product Portfolio
22.4.3.3. Key Financials
22.4.3.4. Sales Footprint
22.4.3.5. SWOT Analysis
22.4.3.6. Strategy Overview
22.4.3.6.1. Marketing Strategy
22.4.3.6.2. Product Strategy
22.4.3.6.3. Channel Strategy
22.4.4. AVA Biomedical
22.4.4.1. Overview
22.4.4.2. Product Portfolio
22.4.4.3. Key Financials
22.4.4.4. Sales Footprint
22.4.4.5. SWOT Analysis
22.4.4.6. Strategy Overview
22.4.4.6.1. Marketing Strategy
22.4.4.6.2. Product Strategy
22.4.4.6.3. Channel Strategy
22.4.5. ICU Medical
22.4.5.1. Overview
22.4.5.2. Product Portfolio
22.4.5.3. Key Financials
22.4.5.4. Sales Footprint
22.4.5.5. SWOT Analysis
22.4.5.6. Strategy Overview
22.4.5.6.1. Marketing Strategy
22.4.5.6.2. Product Strategy
22.4.5.6.3. Channel Strategy
22.4.6. ANGEL Electronics
22.4.6.1. Overview
22.4.6.2. Product Portfolio
22.4.6.3. Key Financials
22.4.6.4. Sales Footprint
22.4.6.5. SWOT Analysis
22.4.6.6. Strategy Overview
22.4.6.6.1. Marketing Strategy
22.4.6.6.2. Product Strategy
22.4.6.6.3. Channel Strategy
22.4.7. B. Braun
22.4.7.1. Overview
22.4.7.2. Product Portfolio
22.4.7.3. Key Financials
22.4.7.4. Sales Footprint
22.4.7.5. SWOT Analysis
22.4.7.6. Strategy Overview
22.4.7.6.1. Marketing Strategy
22.4.7.6.2. Product Strategy
22.4.7.6.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports
Multi-therapy Infusion Pumps Market
